Literature DB >> 27573859

MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways.

Seung-Shick Shin1, Sung-Soo Park1, Byungdoo Hwang2, Bokyung Moon2, Won Tae Kim3, Wun-Jae Kim3, Sung-Kwon Moon2.   

Abstract

Cancers often utilize microRNAs to suppress tumor suppressor genes, thus facilitating their potential for growth and invasion. In the present study, we report the novel findings that miR-892b inhibits proliferation, migration and invasion of bladder cancer cells. The basal expression level of miR‑892b was significantly lower in 3 different bladder cancer cell lines than in normal human urothelial cells. Transfection of miR-892b mimics to bladder cancer cells resulted in dose‑dependent growth arrest. Flow cytometric analysis of the cell cycle showed that miR-892b-transfected bladder cancer cells were subject to arrest in the G1 phase, which was due to the downregulation of cyclin D1 and CDK6 followed by upregulation of p19ARF. In addition, overexpression of miR-892b impeded the migration and invasion of EJ cells. Expression of MMP-9 in EJ cells was blocked by transfection of miR-892b; the effect was regulated, at least in part, by activation of the Sp-1 transcription factor. Overall, we verified that miR-892b regulates the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 signaling networks in bladder cancer cells and may provide a treatment option for advanced-stage bladder cancers.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27573859     DOI: 10.3892/or.2016.5052

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

1.  MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway.

Authors:  Huaqing Yan; Jiangfeng Li; Yufan Ying; Haiyun Xie; Hong Chen; Xin Xu; Xiangyi Zheng
Journal:  Cell Cycle       Date:  2018-12-18       Impact factor: 4.534

2.  miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1.

Authors:  Chenyang Li; Yue Wang; Hao Wang; Bowen Wang; Yunxia Wang; Nan Li; Yanli Qin; Yesheng Wang
Journal:  Anal Cell Pathol (Amst)       Date:  2021-08-05       Impact factor: 2.916

3.  Downregulation of Talin-1 expression associates with increased proliferation and migration of vascular smooth muscle cells in aortic dissection.

Authors:  Xiaolong Wei; Yudong Sun; Yani Wu; Jiang Zhu; Bin Gao; Han Yan; Zhiqing Zhao; Jian Zhou; Zaiping Jing
Journal:  BMC Cardiovasc Disord       Date:  2017-06-20       Impact factor: 2.298

4.  Long noncoding RNA ZFAS1 promotes tumorigenesis and metastasis in nasopharyngeal carcinoma by sponging miR-892b to up-regulate LPAR1 expression.

Authors:  Jiaojiao Peng; Feng Liu; Hong Zheng; Qi Wu; Shixi Liu
Journal:  J Cell Mol Med       Date:  2019-12-18       Impact factor: 5.310

Review 5.  ChrXq27.3 miRNA cluster functions in cancer development.

Authors:  Kosuke Yoshida; Akira Yokoi; Yusuke Yamamoto; Hiroaki Kajiyama
Journal:  J Exp Clin Cancer Res       Date:  2021-03-25

Review 6.  Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances.

Authors:  Zhenhua Yin; Juanjuan Zhang; Lin Chen; Qingfeng Guo; Baocheng Yang; Wei Zhang; Wenyi Kang
Journal:  Biomed Res Int       Date:  2020-12-01       Impact factor: 3.411

7.  The Status of EGFR Modulates the Effect of miRNA-200c on ZEB1 Expression and Cell Migration in Glioblastoma Cells.

Authors:  Lisandra Muñoz-Hidalgo; Teresa San-Miguel; Javier Megías; Eva Serna; Silvia Calabuig-Fariñas; Daniel Monleón; Rosario Gil-Benso; Miguel Cerdá-Nicolás; Concha López-Ginés
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

8.  Dynamic Changes in Plasma MicroRNAs Have Potential Predictive Values in Monitoring Recurrence and Metastasis of Nasopharyngeal Carcinoma.

Authors:  Xia Xu; Juan Lu; Fan Wang; Xiong Liu; Xiaohong Peng; Bolong Yu; Feipeng Zhao; Xiangping Li
Journal:  Biomed Res Int       Date:  2018-01-18       Impact factor: 3.411

9.  Low expression of KCNN3 may affect drug resistance in ovarian cancer.

Authors:  Xia Liu; Luwei Wei; Bingbing Zhao; Xiangxue Cai; Caihua Dong; Fuqiang Yin
Journal:  Mol Med Rep       Date:  2018-05-31       Impact factor: 2.952

10.  Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.

Authors:  Chen Huang; Jie Zhao; Yuelin Zhu
Journal:  J Am Heart Assoc       Date:  2019-12-27       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.